Table 4

CRF identification and management by rheumatologists in RA; PCPs in RA, DM, and the GP

Group A (RA)

Rh

Group A (RA)

PCP

Group B (DM)

Group C (GP)

P, Group A (Rh versus PCP)

P, all three (PCP)

P, A versus C (PCP)

Smoking

ID

52 (21%)

167 (67%)

161 (64%)

188 (75%)

< 0.0001

0.02

0.0496

MA

32 (13%)

25 (10%)

28 (11%)

39 (16%)

0.4

0.1

0.08

Weight

ID

67 (27%)

111 (44%)

191 (76%)

136 (54%)

< 0.0001

< 0.0001

0.03

MA

15 (6%)

72 (29%)

159 (63%)

99 (39%)

< 0.0001

< 0.0001

0.01

BP

ID

233 (93%)

243 (97%)

250 (99.6%)

250 (99.6%)

0.07

0.04

MA

14 (6%)

53 (21%)

169 (67%)

80 (32%)

< 0.0001

< 0.0001

0.008

HDL

ID

13 (5%)

109 (43%)

190 (76%)

144 (57%)

< 0.0001

< 0.0001

0.002

MA

5 (2%)

34 (14%)

137 (55%)

70 (28%)

< 0.0001

< 0.0001

0.0001

LDL

ID

14 (6%)

110 (44%)

197(79%)

146 (58%)

< 0.0001

< 0.0001

0.004

MA

4 (2%)

38 (15%)

160 (64%)

78 (31%)

< 0.0001

< 0.0001

< 0.0001

TG

ID

14 (6%)

109 (43%)

190 (76%)

141 (56%)

< 0.0001

< 0.0001

0.006

MA

5 (2%)

36 (14%)

142 (57%)

70 (28%)

< 0.0001

< 0.0001

0.0003

FBG

ID

3 (1%)

58 (23%)

237 (94%)

68 (27%)

< 0.0001

< 0.0001

0.4

MA

0

7 (3%)

232 (92%)

19 (8%)

0.02

< 0.0001

0.03

Percentages are calculated as the number of patients with an identified or managed risk factor divided by the total number of patients within the group. BP, blood pressure; CRF, cardiovascular risk factor; DM, diabetes mellitus; FBG, fasting blood glucose; GP, general population; HDL, high-density lipoprotein; ID, identified; LD, low-density lipoprotein; MA, managed; PCP, primary care physician; RA, rheumatoid arthritis; Rh, rheumatologist; TG, triglyceride.

Desai et al. Arthritis Research & Therapy 2012 14:R270   doi:10.1186/ar4118